Mutations in Core Gene Region of Hepatitis B Virus in Patients with Chronic Hepatitis B

Insights

Hepatitis B virus (HBV) core gene mutations impact immune responses. Ultra-deep pyrosequencing revealed mutation patterns in T helper, cytotoxic T lymphocyte, and B cell epitopes, with higher frequencies in the C-terminal region, especially in patients with advanced fibrosis.

Area of Science:

  • Virology
  • Immunology
  • Hepatology

Background:

  • Hepatitis B virus (HBV) core protein is crucial for immune response.
  • Mutations in the HBV core gene can alter key epitopes, affecting host immunity.
  • The long-term impact of core gene mutations on HBV infection remains unclear.

Purpose of the Study:

  • To analyze core gene mutations in T lymphocyte (Th and CTL) and B cell epitopes, and the C-terminal region.
  • To investigate these mutations in chronic hepatitis B patients using ultra-deep pyrosequencing (UDPS).

Main Methods:

  • Eleven chronic hepatitis B patients were studied.
  • HBV core gene was amplified using conventional PCR.
  • UDPS was employed to screen mutations in T lymphocyte (Th and CTL) and B cell epitopes, and the C-terminal region.
  • Mutations were analyzed in HBeAg positive and negative patients.

Main Results:

  • Amino acid substitutions ranged from 0.9% (HBeAg positive) to 1.2% (HBeAg negative).
  • Higher missense mutation rates were observed in HBeAg positive patients (p < 0.005).
  • The aa49-69 region showed the highest amino acid substitutions in Th epitopes.
  • C-terminal region mutations were more frequent than in Th, CTL, and B cell regions, and associated with high-grade fibrosis.
  • Specific mutations (V27I, R47H, Y132I, R174STOP, S181P, Q182K) were exclusively found in cirrhotic patients.

Conclusions:

  • Contrary to existing literature, no significant increase in core gene mutations was observed during the anti-HBe positive period.
  • UDPS facilitates understanding the role of low-abundance variants and mutations in the immune system.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
248
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.6K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
599
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
311